Spring til hovednavigation Spring til søgning Spring til hovedindhold

Phase III results for the Novel Neurokinin-1 (NK-1) Receptor Antagonist, Casopitant: Single Oral Dosing Regimen for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients (Pts) Receiving Multiple Cycles of Highly Emetogenic Chemotherapy (HEC)

  • Jørn Herrstedt
  • , J. Rolski
  • , M. Guckert
  • , I. Camlett
  • , M. W. Russo
  • , J. Strausz
  • , Z. Aziz

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning

OriginalsprogEngelsk
Publikationsdato2008
StatusUdgivet - 2008
BegivenhedAmerican Society of Clinical Oncology - Chicago, USA
Varighed: 30. maj 2008 → 3. jun. 2008
Konferencens nummer: 44

Konference

KonferenceAmerican Society of Clinical Oncology
Nummer44
Land/OmrådeUSA
ByChicago
Periode30/05/2008 → 03/06/2008

Citationsformater